--- title: Buy Tasigna Nilotinib 150mg 200mg Pills Online description: Tasigna 150mg and 200mg Pills are used for Philadelphia chromosome-positive chronic myeloid leukemia. Order from our secure online pharmacy for trusted cancer treatment. type: product language: en url: https://liabilis.com/order-tasigna-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 478.79 price_max: 904.39 currency: USD offers: - name: 150mg x 28 pills price: 478.79 - name: 150mg x 56 pills price: 797.99 - name: 200mg x 28 pills price: 559.99 - name: 200mg x 56 pills price: 904.39 --- # Buy Tasigna Nilotinib 150mg 200mg Pills Online Tasigna, containing the active ingredient Nilotinib, is a tyrosine kinase inhibitor developed by Novartis for cancer treatment. It is specifically used for Philadelphia chromosome-positive chronic myeloid leukemia in both adult and pediatric patients. This targeted therapy works by blocking the abnormal protein that causes cancer cell growth. Our pharmacy offers Tasigna in 150mg and 200mg pill formulations. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **150mg** | 28 pills | **$478.79** | $17.10 | In Stock | | **150mg** | 56 pills | **$797.99** | $14.25 | In Stock | | **200mg** | 28 pills | **$559.99** | $20.00 | In Stock | | **200mg** | 56 pills | **$904.39** | $16.15 | In Stock | [Buy Now](https://liabilis.com/order-tasigna-online-en.html) ## Introduction Tasigna is a tablet formulation that contains the active compound nilotinib. It is supplied in 150 mg and 200 mg strengths and belongs to the class of BCR-ABL tyrosine-kinase inhibitors. The medication is primarily prescribed for adults with chronic myeloid leukemia (CML) in chronic or accelerated phase. Nilotinib works by blocking the abnormal enzyme that drives the growth of leukemic cells, thereby helping to achieve and maintain molecular remission. ## Quick Reference Facts ``` **Active Ingredient** : Nilotinib **Form** : pill 150 mg | 200 mg **Primary Uses** : • Treatment of chronic myeloid leukemia (CML) in chronic or accelerated phase ``` ## What is Tasigna? Tasigna is the generic version of medications containing the active compound nilotinib. Nilotinib was originally developed by Novartis and approved by the U.S. Food and Drug Administration (FDA) in 2007 for the treatment of Philadelphia chromosome-positive CML. While the brand name Tasigna is widely recognized, the same molecule is marketed under several brand names such as Tasigna, while generic equivalents containing nilotinib are now available worldwide. As a generic product, Tasigna provides the same pharmacologic effect, bioavailability, and safety profile as the branded formulation, offering patients a cost-effective alternative without compromising therapeutic outcomes. ## How Tasigna Works Nilotinib is a second-generation BCR-ABL tyrosine-kinase inhibitor. In CML, the BCR-ABL fusion gene produces a constitutively active enzyme that drives uncontrolled proliferation of myeloid cells. Nilotinib binds to the ATP-binding site of BCR-ABL, preventing phosphorylation of downstream substrates that are essential for leukemic cell survival. This inhibition halts the signaling cascade, induces apoptosis of malignant cells, and allows normal hematopoiesis to recover. Pharmacokinetically, nilotinib is rapidly absorbed after oral administration, with peak plasma concentrations occurring 3-4 hours post-dose. It is extensively metabolized by CYP3A4 and eliminated primarily via feces. Food markedly increases its bioavailability; therefore, dosing recommendations advise taking Tasigna on an empty stomach (at least 2 hours before or after a meal). The drug’s half-life averages 17 hours, supporting a twice-daily dosing schedule for the approved 200 mg and 300 mg total daily doses. ## Conditions Treated with Tasigna - **Chronic Myeloid Leukemia (CML), chronic phase** Nilotinib targets the BCR-ABL protein that defines CML, leading to high rates of complete cytogenetic response and long-term survival when used as first-line therapy. - **Chronic Myeloid Leukemia, accelerated phase** In patients whose disease has progressed beyond the chronic phase, nilotinib helps to regain molecular control and can delay progression to blast crisis. - **Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph-ALL) - investigational** Although not formally approved, clinical studies have explored nilotinib in combination regimens for Ph-ALL, showing encouraging molecular response rates. (Off-label use must be supervised by a specialist.) ## Is Tasigna the Right Medication for You? Tasigna is appropriate for adult patients diagnosed with Philadelphia chromosome-positive CML who require a potent BCR-ABL inhibitor, especially those who have failed first-generation therapies such as imatinib. It is also considered when rapid molecular response is a treatment goal. Ideal candidates are individuals with adequate hepatic and renal function, no history of severe cardiovascular disease, and who can adhere to the strict fasting schedule required for optimal absorption. Contraindications include: - Known hypersensitivity to nilotinib or any tablet excipients. - Existing QT-interval prolongation or a history of ventricular arrhythmias. - Concomitant use of strong CYP3A4 inducers (e.g., rifampin, carbamazepine) that markedly reduce nilotinib exposure. Patients with uncontrolled hypertension, active infections, or significant hepatic impairment should be evaluated carefully, as the risk-benefit balance may be unfavorable. ## Buying Tasigna from [our online pharmacy](https://liabilis.com/order-tasigna-online-en.html) ### Why Choose Our Service? Accessing Tasigna can be challenging due to regional price differentials and occasional supply constraints. [our online pharmacy](https://liabilis.com/order-tasigna-online-en.html) offers a reliable channel to obtain the medication at a price close to the wholesale cost, helping patients avoid markup while preserving therapeutic continuity. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Each shipment is sourced from manufacturers that comply with Good Manufacturing Practice (GMP) standards and is inspected by certified pharmacists before dispatch. ### Pricing & Access The generic formulation of nilotinib is substantially less expensive than the branded Tasigna, yet it delivers identical therapeutic effect. Our pharmacy service provides transparent pricing, bulk-order discounts, and flexible payment options, making long-term treatment financially sustainable. ### Discreet Delivery All orders are packed in unmarked, tamper-evident packaging. Standard shipping typically arrives within 7 days, while express delivery can be arranged for a modest additional fee. Privacy is maintained throughout the ordering and fulfillment process. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing** - 150 mg tablet: two tablets taken twice daily (total 600 mg per day). - 200 mg tablet: one tablet taken twice daily (total 400 mg per day). Adjustments may be made by the treating physician based on response and tolerability. - **Missed dose** If a dose is missed, take it as soon as you remember **provided at least 2 hours have not passed** since the next scheduled dose. Do **not** double-dose to compensate. - **Overdose** In the event of an accidental overdose, seek immediate medical attention. Symptoms may include severe nausea, vomiting, dizziness, and cardiac arrhythmias. Contact your local poison control centre or emergency department promptly. - **Practical precautions** - Take Tasigna on an empty stomach (no food 2 hours before and after). - Avoid grapefruit and grapefruit juice, which can increase serum concentrations. - Refrain from operating heavy machinery until you know how the medication affects you, as dizziness or visual disturbances can occur. - Limit alcohol consumption; it may exacerbate hepatic side-effects. ## Safety Information ### ⚠️ Who Should Not Take Tasigna - Patients with a known hypersensitivity to nilotinib or any tablet component. - Individuals with a baseline QTc interval > 450 ms (men) or > 470 ms (women). - Those receiving strong CYP3A4 inducers (e.g., phenytoin, St. John’s wort). ### Common Side Effects - **Rash or skin discoloration** - generally mild; moisturisers may help. - **Elevated lipase/amylase** - monitor pancreatic enzymes; adjust dose if severe. - **Myalgia or arthralgia** - can be mitigated with acetaminophen if needed. ### Serious Side Effects (Seek Immediate Medical Help) - **Cardiac arrhythmias or sudden syncope** - may signal QT prolongation. - **Severe liver injury** - indicated by jaundice, dark urine, or persistent fatigue. - **Pancreatitis** - abrupt abdominal pain radiating to the back, accompanied by nausea/vomiting. ### Drug & Food Interactions - **CYP3A4 inhibitors** (e.g., ketoconazole, clarithromycin) → increase nilotinib levels; dose reduction may be required. - **CYP3A4 inducers** (e.g., rifampin, carbamazepine) → reduce efficacy; avoid co-administration. - **Antacids containing aluminum or magnesium** → may lower absorption if taken within 2 hours of Tasigna. - **Warfarin** → nilotinib may enhance anticoagulant effect; monitor INR closely. ## Off-Label and Investigational Uses of Tasigna - **Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-ALL)** - small phase II trials have combined nilotinib with chemotherapy, reporting improved molecular remission rates. This approach remains investigational and should only be pursued within a clinical trial or specialized hematology practice. - **Chronic myeloid leukemia after transplantation** - case series suggest nilotinib can maintain disease control in post-allogeneic stem-cell transplant patients who relapse. Evidence is limited; therapy must be individualized. All off-label applications lack formal regulatory approval and must be prescribed under strict specialist supervision. ## Storage & Handling - Store tablets at 20-25 °C (68-77 °F) in a dry place away from direct sunlight. - Do not refrigerate or freeze. - Keep the container tightly closed to protect from moisture. - Dispose of unused tablets according to local pharmacy waste guidelines or bring them to a medication take-back program. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Tasigna?** Yes, but carry a copy of your prescription and a letter from your physician describing the medical necessity. Keep the medication in its original packaging to avoid customs issues. - **Will taking Tasigna affect my ability to drive?** Some patients experience dizziness or visual disturbances, especially when therapy is initiated. Assess your own response before operating a vehicle, and discuss any concerns with your clinician. - **Is it safe to take Tasigna while fasting for religious observances?** Tasigna must be taken on an empty stomach; fasting may actually align with dosing requirements. However, ensure you still observe the 2-hour window before and after meals to maintain consistent absorption. **Product & Formulation Details** - **What do Tasigna tablets look like?** The 150 mg tablets are typically white, round, debossed with “150” on one side; the 200 mg tablets are orange, oval, and marked with “200”. Appearance may vary slightly between manufacturers. - **Are there any inactive ingredients I should be aware of?** Common excipients include lactose, magnesium stearate, and microcrystalline cellulose. Patients with severe lactose intolerance should discuss alternatives with their pharmacist. **Regulatory & Safety Nuances** - **Can Tasigna be detected in standard drug-testing panels?** Nilotinib is not screened for in most employment or sports drug tests, but specialized assays can detect it if specifically requested. - **Is Tasigna approved for use in patients over 75 years old?** The clinical trials included older adults, and the drug is approved for all adult age groups. Nonetheless, clinicians often monitor older patients more closely for cardiac and hepatic toxicity. - **Do I need to inform my insurance provider when ordering Tasigna online?** Insurance coverage varies. Some plans reimburse for generic nilotinib obtained through accredited pharmacies, while others may require prior authorization. Review your policy details before purchase. **Scientific & Clinical Curiosity** - **What distinguished nilotinib from first-generation inhibitors like imatinib?** Nilotinib binds more tightly to the ATP-binding pocket of BCR-ABL and retains activity against many imatinib-resistant mutations, resulting in faster and deeper molecular responses. - **Which clinical trial led to the FDA approval of nilotinib?** The pivotal ENESTnd (Evaluating Nilotinib Efficacy and Safety in a Trial - New Drugs) phase III study demonstrated superior rates of complete cytogenetic response compared with imatinib, forming the basis for approval. ## Glossary **BCR-ABL** : An abnormal fusion protein produced by the Philadelphia chromosome that drives uncontrolled cell division in CML. **Tyrosine-Kinase Inhibitor (TKI)** : A class of drugs that block enzymes responsible for signaling pathways that promote cancer cell growth. **QT Interval** : A measurement on an electrocardiogram reflecting the time for ventricular depolarization and repolarization; prolongation can predispose to dangerous arrhythmias. **Bioavailability** : The proportion of an orally administered dose that reaches systemic circulation in an active form. **GMP (Good Manufacturing Practice)** : International standards ensuring that pharmaceutical products are consistently produced and controlled according to quality standards. ## Disclaimer The information presented about Tasigna is intended for general educational purposes and does not substitute personalized medical advice. Treatment choices, including any off-label applications, should be made only under the guidance of a qualified healthcare professional. Readers are presumed to be responsible adults capable of making informed health decisions. [our online pharmacy](https://liabilis.com/order-tasigna-online-en.html) provides access to Tasigna for individuals who may encounter limited availability through conventional channels or who seek cost-effective generic alternatives. Always discuss with your physician before initiating, altering, or discontinuing any medication.